MOH — authorised 20 November 1964
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
MOH authorised Norpramin on 20 November 1964
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 20 November 1964.
SANOFI AVENTIS US holds the Israeli marketing authorisation.